The diagnosis of the legendary actor Amitabh Bachchan with liver cirrhosis made the disease the talk of all of India. However, the condition known as fatty liver, which starts in the majority of people, progresses to liver cirrhosis in the later stages. Contrary to common belief, non-drinkers are also at risk for developing a fatty liver, especially if they struggle with conditions like diabetes, obesity, or high blood cholesterol.

About 30% of the world’s population today suffers from fatty liver, one of the most prevalent diseases. According to reports, NAFLD affects over 30% of the population overall in India and more than 50% of people with risk factors including obesity and diabetes.

To provide holistic treatment and to generate awareness about Fatty Liver, Apollo Multispeciality Hospitals launched the Comprehensive Fatty Liver Clinic. This clinic will adopt the most contemporary investigational approach to detect asymptomatic fatty liver and provide the most advanced treatment.

Dr. Mahesh K Goenka – DME & Director & Head Institute of Gastrosciences& Liver Transplant Apollo Multispeciality Hospitals and Dr. Surinder Singh Bhatia– DMS (Director Medical Services) graced the launch of this clinic.

Due to the disease’s quiet onset—one in which there are no significant early warning signs—it is crucial to conduct the necessary investigations. Thus, the need for the value of preventative diagnostics such as Liver Function Tests (LFT) and Ultrasounds (USG). For the first time in Eastern India, Apollo, a leader in healthcare, introduces the most cutting-edge way of fatty liver testing, comprising fibroscan and MRI-based tests like MRI-PDFF and MR Elastography. These tests can detect the illness at an extremely early stage, which will aid patients in recovering more quickly and avoiding reaching a very critical stage.

With early detection and lifestyle modification, fatty liver is curable.

Priyanka Dutta